(IMMU) |
| 0 (0%) 05-23 18:42 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 10.48 |
| Resistance 1: | 10.29 |
| Pivot price: | 10.14 |
| Support 1: | 9.98 |
| Support 2: | 8.30 |
| 52w High: | |
| 52w Low: |
| EPS | 0.040 |
| Book Value | 11.100 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.708 |
| Profit Margin (%) | 6.39 |
| Operating Margin (%) | 79.04 |
| Return on Assets (ttm) | 2.1 |
| Return on Equity (ttm) | 0.4 |
Fri, 08 May 2026
IMMU: Reduced costs and strong cash position support ongoing AML and CML clinical trial progress - TradingView
Fri, 08 May 2026
IMMU: Broader clinical focus in AML and CML, reduced costs, and strong cash position drive progress - TradingView
Fri, 08 May 2026
IMMU: Clinical expansion in AML and CML, narrowed losses, but liquidity risk remains - TradingView
Tue, 11 Nov 2025
Fuzon comes back after six years with new vocalist - The Express Tribune
Thu, 06 Nov 2025
Mikku Immu blends health and taste with fermented ingredients, vitamin C and 4,000mg of fibre - Mini Me Insights
Mon, 10 Feb 2025
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants - Nature
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |